Different subcellular localizations and functions of human ARD1 variants

International Journal of Oncology

Volumn 46, Issue 2, 2015, Pages 701-707

  Seo, Ji Hae ^a   Park, Ji Hyeon ^a   Lee, Eun Ji ^a   Kim, Kyu Won ^a,b  

^a Seoul National University   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

ARD1; Cancer cells; Proliferation; Splice variant

Indexed keywords

AMINO ACID; CYCLIN D1; MESSENGER RNA; PEPTIDE ALPHA N ACETYLTRANSFERASE; PROTEIN; PROTEIN HARD1; UNCLASSIFIED DRUG; ISOPROTEIN; NAA10 PROTEIN, HUMAN; PEPTIDE ALPHA N ACETYLTRANSFERASE A; PEPTIDE ALPHA N ACETYLTRANSFERASE E;

ACETYLATION; ALTERNATIVE RNA SPLICING; ARTICLE; BIOLOGICAL FUNCTIONS; CARBOXY TERMINAL SEQUENCE; CELL GROWTH; CELL NUCLEUS; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; ENZYME ACTIVITY; GENE DELETION; GENETIC VARIABILITY; HELA CELL LINE; HUMAN; HUMAN CELL; NUCLEAR LOCALIZATION SIGNAL; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN FUNCTION; SEQUENCE ALIGNMENT; UPREGULATION; ANIMAL; BIOSYNTHESIS; GENE EXPRESSION REGULATION; GENETICS; MOUSE;

ACETYLATION; ALTERNATIVE SPLICING; ANIMALS; CELL PROLIFERATION; CYCLIN D1; GENE EXPRESSION REGULATION, NEOPLASTIC; HELA CELLS; HUMANS; MICE; N-TERMINAL ACETYLTRANSFERASE A; N-TERMINAL ACETYLTRANSFERASE E; PROTEIN ISOFORMS; SEQUENCE ALIGNMENT;

EID: 84918581492     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2014.2770     Document Type: Article

References (29)

1. Driessen HP, de Jong WW, Tesser GI and Bloemendal H: The mechanism of N-terminal acetylation of proteins. CRC Crit Rev Biochem 18: 281-325, 1985.
2. Jeong JW, Bae MK, Ahn MY, et al: Regulation and destabilization of HIF-1alpha by ARD1-mediated acetylation. Cell 111: 709-720, 2002.
3. Lim JH, Park JW and Chun YS: Human arrest defective 1 acetylates and activates beta-catenin, promoting lung cancer cell proliferation. Cancer Res 66: 10677-10682, 2006.
4. Ohkawa N, Sugisaki S, Tokunaga E, et al: N-acetyltransferase ARD1-NAT1 regulates neuronal dendritic development. Genes Cells 13: 1171-1183, 2008.
5. Shin DH, Chun YS, Lee KH, Shin HW and Park JW: Arrest defective-1 controls tumor cell behavior by acetylating myosin light chain kinase. PLoS One 4: e7451, 2009.
6. Wang Z, Wang Z, Guo J, et al: Inactivation of androgen-induced regulator ARD1 inhibits androgen receptor acetylation and prostate tumorigenesis. Proc Natl Acad Sci USA 109: 3053-3058, 2012.
7. K uo HP, Lee DF, Chen CT, et al: ARD1 stabilization of TSC2 suppresses tumorigenesis through the mTOR signaling pathway. Sci Signal 3: ra9, 2010.
8. Xu H, Jiang B, Meng L, et al: N-α-acetyltransferase 10 protein inhibits apoptosis through RelA/p65-regulated MCL1 expression. Carcinogenesis 33: 1193-1202, 2012.
9. Yi CH, Sogah DK, Boyce M, Degterev A, Christofferson DE and Yuan J: A genome-wide RNAi screen reveals multiple regulators of caspase activation. J Cell Biol 179: 619-626, 2007.
10. Arnesen T, Gromyko D, Pendino F, Ryningen A, Varhaug JE and Lillehaug JR: Induction of apoptosis in human cells by RNAi-mediated knockdown of hARD1 and NATH, components of the protein N-alpha-acetyltransferase complex. Oncogene 25: 4350-4360, 2006.
11. Asaumi M, Iijima K, Sumioka A, et al: Interaction of N-terminal acetyltransferase with the cytoplasmic domain of beta-amyloid precursor protein and its effect on A beta secretion. J Biochem 137: 147-155, 2005.
12. Arnesen T, Anderson D, Baldersheim C, Lanotte M, Varhaug JE and Lillehaug JR: Identification and characterization of the human ARD1-NATH protein acetyltransferase complex. Biochem J 386: 433-443, 2005.
13. K uo HP and Hung MC: Arrest-defective-1 protein (ARD1): tumor suppressor or oncoprotein? Am J Transl Res 2: 56-64, 2010.
14. K alvik TV and Arnesen T: Protein N-terminal acetyltransferases in cancer. Oncogene 32: 269-276, 2013.
15. Arnesen T, Thompson PR, Varhaug JE and Lillehaug JR: The protein acetyltransferase ARD1: a novel cancer drug target? Curr Cancer Drug Targets 8: 545-553, 2008.
16. Shim JH, Chung YH, Kim JA, et al: Clinical implications of arrest-defective protein 1 expression in hepatocellular carcinoma: a novel predictor of microvascular invasion. Dig Dis 30: 603-608, 2012.
17. Wang ZH, Gong JL, Yu M, et al: Up-regulation of human arrestdefective 1 protein is correlated with metastatic phenotype and poor prognosis in breast cancer. Asian Pac J Cancer Prev 12: 1973-1977, 2011.
18. Yu M, Gong J, Ma M, et al: Immunohistochemical analysis of human arrest-defective-1 expressed in cancers in vivo. Oncol Rep 21: 909-915, 2009.
19. Ren T, Jiang B, Jin G, et al: Generation of novel monoclonal antibodies and their application for detecting ARD1 expression in colorectal cancer. Cancer Lett 264: 83-92, 2008.
20. Arnesen T, Gromyko D, Horvli O, Fluge O, Lillehaug J and Varhaug JE: Expression of N-acetyl transferase human and human arrest defective 1 proteins in thyroid neoplasms. Thyroid 15: 1131-1136, 2005.
21. Seo JH, Cha JH, Park JH, et al: Arrest defective 1 autoacetylation is a critical step in its ability to stimulate cancer cell proliferation. Cancer Res 70: 4422-4432, 2010.
22. Chun KH, Cho SJ, Choi JS, Kim SH, Kim KW and Lee SK: Differential regulation of splicing, localization and stability of mammalian ARD1235 and ARD1225 isoforms. Biochem Biophys Res Commun 353: 18-25, 2007.
23. K im SH, Park JA, Kim JH, et al: Characterization of ARD1 variants in mammalian cells. Biochem Biophys Res Commun 340: 422-427, 2006.
24. Arnesen T, Kong X, Evjenth R, et al: Interaction between HIF-1 alpha (ODD) and hARD1 does not induce acetylation and destabilization of HIF-1 alpha. FEBS Lett 579: 6428-6432, 2005.
25. Bilton R, Mazure N, Trottier E, et al: Arrest-defective-1 protein, an acetyltransferase, does not alter stability of hypoxia-inducible factor (HIF)-1alpha and is not induced by hypoxia or HIF. J Biol Chem 280: 31132-31140, 2005.
26. Fisher TS, Etages SD, Hayes L, Crimin K and Li B: Analysis of ARD1 function in hypoxia response using retroviral RNA interference. J Biol Chem 280: 17749-17757, 2005.
27. Lee MN, Lee SN, Kim SH, et al: Roles of arrest-defective protein 1(225) and hypoxia-inducible factor 1alpha in tumor growth and metastasis. J Natl Cancer Inst 102: 426-442, 2010.
28. Brett D, Pospisil H, Valcarcel J, Reich J and Bork P: Alternative splicing and genome complexity. Nat Genet 30: 29-30, 2002.
29. Nilsen TW and Graveley BR: Expansion of the eukaryotic proteome by alternative splicing. Nature 463: 457-463, 2010.